Skip to main content

and
  1. Article

    Open Access

    Pharmacological inhibition of METTL3 impacts specific haematopoietic lineages

    Katherine Sturgess, Eliza Yankova, M. S. Vijayabaskar, Tomoya Isobe in Leukemia (2023)

  2. Article

    Open Access

    Identification of the ultrahigh-risk subgroup in neuroblastoma cases through DNA methylation analysis and its treatment exploiting cancer metabolism

    Neuroblastomas require novel therapies that are based on the exploitation of their biological mechanism. To address this need, we analyzed the DNA methylation and expression datasets of neuroblastomas, extract...

    Kentaro Watanabe, Shunsuke Kimura, Masafumi Seki, Tomoya Isobe, Yasuo Kubota in Oncogene (2022)

  3. Article

    Open Access

    Integrated multiomics analysis of hepatoblastoma unravels its heterogeneity and provides novel druggable targets

    Although hepatoblastoma is the most common pediatric liver cancer, its genetic heterogeneity and therapeutic targets are not well elucidated. Therefore, we conducted a multiomics analysis, including mutatome, ...

    Masahiro Sekiguchi, Masafumi Seki, Tomoko Kawai, Kenichi Yoshida in npj Precision Oncology (2020)

  4. No Access

    Article

    DNA methylation-based classification reveals difference between pediatric T-cell acute lymphoblastic leukemia and normal thymocytes

    Shunsuke Kimura, Masafumi Seki, Tomoko Kawai, Hiroaki Goto, Kenichi Yoshida in Leukemia (2020)

  5. No Access

    Article

    Aggressive transformation of anaplastic large cell lymphoma with increased number of ALK-translocated chromosomes

    Pediatric anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma (ALCL) usually has a benign clinical course. A small fraction of patients with ALCL develops an aggressive clinical course; ho...

    Akihiro Hoshino, Keiko Nomura, Takeru Hamashima in International Journal of Hematology (2015)